SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines

Cancer Letters
Chung-Pu WuSuresh V Ambudkar

Abstract

One of the major challenges in cancer chemotherapy is the development of multidrug resistance phenomenon attributed to the overexpression of ATP-binding cassette (ABC) transporter ABCB1 or ABCG2 in cancer cells. Therefore, re-sensitizing MDR cancer cells to chemotherapy by directly inhibiting the activity of ABC transporters has clinical relevance. Unfortunately, previous attempts of developing clinically applicable synthetic inhibitors have failed, mostly due to problems associated with toxicity and unforeseen drug-drug interactions. An alternative approach is by repositioning drugs with known pharmacological properties as modulators of ABCB1 and ABCG2. In this study, we discovered that the transport function of ABCB1 and ABCG2 is strongly inhibited by SIS3, a specific inhibitor of Smad3. More importantly, SIS3 enhances drug-induced apoptosis and resensitizes ABCB1- and ABCG2-overexpressing cancer cells to chemotherapeutic drugs at non-toxic concentrations. These findings are further supported by ATPase assays and by a docking analysis of SIS3 in the drug-binding pockets of ABCB1 and ABCG2. In summary, we revealed an additional action of SIS3 that re-sensitizes MDR cancer cells and a combination therapy with this drug and othe...Continue Reading

References

May 11, 1994·Biochimica Et Biophysica Acta·Z HollóB Sarkadi
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
Jan 31, 2002·Annual Review of Medicine·Michael M Gottesman
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Apr 5, 2003·Toxicology Letters·Adrienn BodóBalázs Sarkadi
Oct 25, 2003·Oncogene·Suresh V AmbudkarMichael M Gottesman
Feb 20, 2004·Cancer Research·Robert W RobeySusan E Bates
Mar 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kiyotaka YohAtsushi Ochiai
Oct 20, 2004·Cancer Research·Clinton F StewartPeter J Houghton
Dec 21, 2004·Leukemia Research·Bertil UgglaUlf Tidefelt
Jun 16, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takeshi KitazakiShigeru Kohno
Nov 23, 2005·Bioinformatics·Konstantin ArnoldTorsten Schwede
May 3, 2006·Cancer Research·Markos LeggasClinton F Stewart
Feb 6, 2008·Expert Opinion on Drug Metabolism & Toxicology·Suneet ShuklaSuresh V Ambudkar
Dec 9, 2008·Biochemical Pharmacology·Zhi ShiZhe-Sheng Chen
Dec 2, 2009·Methods in Molecular Biology·Jean-Pierre Gillet, Michael M Gottesman
Dec 8, 2010·Bioinformatics·Pascal BenkertTorsten Schwede
Jul 21, 2011·Molecular Pharmaceutics·Chung-Pu WuYu-Shan Wu
Aug 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C HofmeisterMitch A Phelps
Oct 4, 2012·Bioorganic & Medicinal Chemistry Letters·María L CuestasVerónica L Mathet
Feb 14, 2014·Pharmacogenomics and Personalized Medicine·Kohji NoguchiYoshikazu Sugimoto

❮ Previous
Next ❯

Citations

Oct 7, 2020·Fundamental & Clinical Pharmacology·Dao-Cai WangYong-Mei Xie
Jan 13, 2021·Drug Delivery and Translational Research·Shuanghu WangJingbo Hu
Apr 29, 2021·Expert Opinion on Drug Discovery· FaheemSankaranarayanan Murugesan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.